ADSK
56
3
KHC
49
4
ETR
52
6
PWR
67
8
BF.B
47
-4
DVN
32
-4
GS
68
3
TEL
82
-3
UNP
46
7
NWS
80
2
CCL
70
3
TMO
47
-5
PFE
31
-2
CPB
27
-3
HBI
59
-3
MMC
53
5
MCHP
73
-2
O
42
7
ECL
59
2
PEP
51
12
ADSK
56
3
KHC
49
4
ETR
52
6
PWR
67
8
BF.B
47
-4
DVN
32
-4
GS
68
3
TEL
82
-3
UNP
46
7
NWS
80
2
CCL
70
3
TMO
47
-5
PFE
31
-2
CPB
27
-3
HBI
59
-3
MMC
53
5
MCHP
73
-2
O
42
7
ECL
59
2
PEP
51
12
Financhill
Back

Vanguard Intermediate-Term Corp Bond Idx Fund ETF Vs. Cidara Therapeutics Industry Stock Comparison

Sell
49

VCIT
Vanguard Intermediate-Term Corp Bond Idx Fund ETF

Last Price:
$82.01
Seasonality Move:
0.07%
Buy
77

CDTX
Cidara Therapeutics

Last Price:
$55.28
Seasonality Move:
-8.55%
Sell
49
Vanguard Intermediate-Term Corp Bond Idx Fund ETF (VCIT) is a Sell

Is Vanguard Intermediate-Term Corp Bond Idx Fund ETF a Buy, Sell or Hold?

  • The current Vanguard Intermediate-Term Corp Bond Idx Fund ETF [VCIT] share price is $82.00. The Score for VCIT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • VCIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Cidara Therapeutics (CDTX) is a Buy

Is Cidara Therapeutics a Buy, Sell or Hold?

  • The current Cidara Therapeutics [CDTX] share price is $55.32. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VCIT Stock Price Chart

What is Vanguard Intermediate-Term Corp Bond Idx Fund ETF's stock price today?

  • The Vanguard Intermediate-Term Corp Bond Idx Fund ETF share price today is $82.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VCIT is experiencing slight buying pressure.

CDTX Stock Price Chart

What is Cidara Therapeutics's stock price today?

  • The Cidara Therapeutics share price today is $55.32
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

VCIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 20.27 Buy
Relative Strength Index (14 RSI): 49.66 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (81.56 - 82.52) Sell
Bollinger Bands (100): (80.75 - 82.03) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.91 Buy
Relative Strength Index (14 RSI): 81.84 Buy
Chaikin Money Flow: 1154906 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.31 - 51.77) Buy
Bollinger Bands (100): (15.88 - 36.04) Buy

VCIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 82.23 Sell
20-day SMA: 82.2 Sell
50-day SMA: 81.58 Buy
200-day SMA: 81.4 Buy
8-day EMA: 58.73 Buy
20-day EMA: 32.33 Buy
50-day EMA: 14.89 Buy
200-day EMA: 4.01 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.39 Buy
20-day SMA: 42.46 Buy
50-day SMA: 30.72 Buy
200-day SMA: 21.84 Buy
8-day EMA: 50.49 Buy
20-day EMA: 44.06 Buy
50-day EMA: 34.72 Buy
200-day EMA: 23.97 Buy

Vanguard Intermediate-Term Corp Bond Idx Fund ETF Earnings Growth & VCIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cidara Therapeutics Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.

Vanguard Intermediate-Term Corp Bond Idx Fund ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):